U.S. Markets closed

Pfizer to buy Array BioPharma, strike $10.6B deal

Pfizer is buying Array BioPharma in a deal valued at $10.6 billion. Yahoo Finance’s Alexis Christoforous and Brian Sozzi discuss the deal and how it will impact pharmaceutical stocks.